Skip to content Skip to sidebar Skip to footer
central building

NKUA ranked 92nd globally and 25th in Europe in AD Scientific Index World Scientist and University Rankings 2023

The AD Scientific Index World Scientist and University Rankings 2023 reflect a significant distinction demonstrating the high quality, global impact, and recognition of NKUA’s research work. More specifically, the Institution ranks 92nd globally out of 19,514 Universities from 216 countries included in…

Read More

hub image 8996

Professor Charalambos Tsitouras of the General Department of NKUA in the World’s Top 2% Scientists list

On October 10, 2022, two lists concerning the World’s Top 2% Scientists were announced. One considers the year 2021 and the other the entire work of the scientists. According to this database, Charalambos Tsitouras, Professor of Mathematics in the General department, is…

Read More

terpos

Honorary distinction for Professor of Hematology of NKUA Evangelos Terpos: researcher with the largest number of citations from one publication of the American Journal of Hematology in the two-year period 2019-2020

During the Annual Conference of the American Society of Hematology in New Orleans on 11/12/2022, Evangelos Terpos, Professor of Therapeutics-Hematology of the National and Kapodistrian University of Athens, was honored by the editor of the journal American Journal of Hematology Carlo Brugnara, Professor of…

Read More

Social media Winners photo 1024x768 1

The NKUA School of Law team won the All-European International Humanitarian and Refugee Law Moot Court Competition 2022

This year, our team competed, for the first time, in the All-European International Humanitarian and Refugee Law Moot Court Competition, and, after a challenging and thrilling final round against Sofia University ‘St Kliment Ohridski’, was declared the winner by a unanimous decision!

Read More

puzzle gf85d879af 1280

Publication of the study «Towards personalized immunotherapy in sepsis», with co-ordinating investigator E.J. Giamarellos-Bourboulis, at the journal Cell Reports Medicine

On 15 November 2022 the high impact journal Cell Reports Medicine published the study «Towards personalized immunotherapy in sepsis». The study is describing the results of the PROVIDE trial that took place in 11 study sites in Greece; three of the sites are…

Read More

UoA © 2024. All Rights Reserved

Skip to content
GR